Professor Dyfrig Hughes

Portrait of Prof Dyfrig Hughes

Professor Dyfrig Hughes graduated in pharmacy at Cardiff University before undertaking a PhD in cardiovascular pharmacology at the University of Liverpool. He is currently Professor of Pharmacoeconomics and co-director of the Centre for Health Economics and Medicines Evaluation, Bangor University. He is also an honorary professor at the Department of Molecular and Clinical Pharmacology, University of Liverpool, and visiting professor at the Università di Torino.
Dyfrig’s research focuses primarily on the safe, effective and efficient use of medicines. His research has resulted in over 200 publications, including in the prestigious medical journals New England Journal of Medicine, Lancet and the BMJ. He has led and contributed to research totalling over £60m in value.

Dyfrig’s involvement in NHS health technology assessment and appraisal, includes leading on the pharmacoeconomic activities of the All Wales Therapeutics and Toxicology Centre (contributing to over 200 substantive Health Technology Assessment reports informing medicines policy in Wales); membership of the All Wales Medicines Strategy Group; and past member of the National Institute for Health and Care Excellence technology appraisal committee.

In 2016 he was awarded Health and Care Research Wales Senior Research Leader. He was inaugural president of the International Society for Medication Adherence and is an elected fellow of: The Learned Society of Wales (2013), The British Pharmacological Society (2013), and the Faculty of the Royal Pharmaceutical Society (2014). He is an editorial board member of the journals PharmacoEconomics, Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology and the Orphanet Journal of Rare Diseases.

Dyfrig leads on the health economic evaluation of azithromycin in the PARROT clinical trial.